Economics Of Electronic Rx Anti-Counterfeit Technology Are Favorable – HDMA Report
This article was originally published in The Pink Sheet Daily
Executive Summary
The financial return from adopting electronic product codes that use radio frequency identification to address Rx supply chain integrity issues would exceed the costs, a Healthcare Distribution Management Association report finds
You may also be interested in...
Radio Frequency ID Could Be Implemented On At Least Limited Scale By 2007, Group Says
Results from a pilot study released by the “Jumpstart” anti-counterfeit coalition indicate that RFID technology could satisfy regulatory and retailer requirements. Pfizer says global standards need to be developed before widespread adoption will occur.
Drug Radio Frequency ID To Be Widespread By 2007, FDA's McClellan Says
FDA expects the anticounterfeit technology will be implemented over a phased-in timeline. Although the agency does not plan to require use, it will take an active role in facilitating adoption of RFID.
U.S. Patents Could Limit President's AIDS Drug Assistance Plan, GAO Says
The U.S. Global AIDS Coordinator's Office suggests it will use its authority to purchase an FDA-approved generic antiretroviral product for which permission could not be obtained from the patent holder. FDA grants tentative approval to a South African firm for a generic co-packaged version of Combivir and Viramune.